Lin Elizabeth Yeu

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 4

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 1,590

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 3

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 3,180

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,547

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

SEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,933

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

SEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 3

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 4,770

F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026.

SEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,320

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

SEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,707

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

SEC source: 0001842190-26-000007 · wk-form4_1773961442.xml · nonDerivative · entry 3

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,308

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

SEC source: 0001842190-26-000007 · wk-form4_1773961442.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,698

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

SEC source: 0001842190-26-000007 · wk-form4_1773961442.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,077

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

SEC source: 0001842190-26-000005 · wk-form4_1773778809.xml · derivative · entry 4

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,534

Underlying: Common Stock · 2,511 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service.

F3 · derivative.expiration_date: RSUs granted on March 5, 2025, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service.

SEC source: 0001842190-26-000005 · wk-form4_1773778809.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").

SEC source: 0001842190-26-000003 · wk-form4_1773086785.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,161

Underlying: Common Stock · 17,161 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.

F3 · derivative.expiration_date: The RSUs will vest in four equal annual installments on March 15th of each of 2027, 2028, 2029, and 2030, subject to the Reporting Person's continuous service.

SEC source: 0001842190-26-000003 · wk-form4_1773086785.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,310

Underlying: Common Stock · 27,310 shares

Expires 2036-03-04

F1 · derivative.exercise_date: 25% of the option shares shall vest on March 5, 2027, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.

SEC source: 0001842190-25-000003 · wk-form4_1766005632.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,941

F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

SEC source: 0001842190-25-000003 · wk-form4_1766005632.xml · derivative · entry 5

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,459

Underlying: Common Stock · 6,819 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F5 · derivative.exercise_date: RSUs granted on November 4, 2024 in connection with the Reporting Person's appointment as Chief Medical Officer. 25% of the RSUs will vest on December 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.

F5 · derivative.expiration_date: RSUs granted on November 4, 2024 in connection with the Reporting Person's appointment as Chief Medical Officer. 25% of the RSUs will vest on December 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.

SEC source: 0001842190-25-000003 · wk-form4_1766005632.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,019

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F2 · balance_after: Since the date of the Reporting Person's last report, 9,506 shares previously owned by the Reporting Person's Spouse's Roth IRA were transferred to the Reporting Person's self-directed IRA and are now directly owned.

SEC source: 0000950170-25-088590 · ownership.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,708

Underlying: Common Stock · 9,708 shares

Expires 2035-06-17

F2 · derivative.exercise_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders.

SEC source: 0000950170-25-088590 · ownership.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,341

Underlying: Common Stock · 5,341 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the right to receive one share of the Corporation's common stock upon vesting.

F2 · derivative.exercise_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders.

F2 · derivative.expiration_date: These equity awards vest in full on the earlier of June 18, 2026, or the Corporation's 2026 Annual Meeting of Shareholders.

SEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,694

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

SEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · derivative · entry 5

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

SEC source: 0001819790-25-000021 · wk-form4_1741382232.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,045

Underlying: Common Stock · 10,045 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service.

F3 · derivative.expiration_date: The RSUs will vest in four equal annual installments on March 15th of each of 2026, 2027, 2028, and 2029, subject to the Reporting Person's continuous service.

SEC source: 0001819790-25-000021 · wk-form4_1741382232.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,314

Underlying: Common Stock · 15,314 shares

Expires 2035-03-04

F1 · derivative.exercise_date: 25% of the option shares shall vest on March 5, 2026, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years, subject to the Reporting Person's continuous service.

SEC source: 0001819790-24-000121 · wk-form4_1730929222.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,278

Underlying: Common Stock · 27,278 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.

SEC source: 0001819790-24-000121 · wk-form4_1730929222.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,074

Underlying: Common Stock · 41,074 shares

Expires 2034-11-03

F1 · derivative.exercise_date: Option granted in connection with the Reporting Person's appointment as Chief Medical Officer as disclosed in the Form 8-K dated November 5, 2024.

SEC source: 0001819790-24-000100 · wk-form4_1719354246.xml · derivative · entry 4

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-24-000100 · wk-form4_1719354246.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

SEC source: 0000950170-24-076855 · ownership.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,010

Underlying: Common Stock · 4,010 shares

Expires 2034-06-19

F1 · security: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders.

SEC source: 0000950170-24-076855 · ownership.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,099

F1 · security: Reflects shares of restricted stock and options to purchase common stock granted on June 20, 2024, pursuant to the Corporation's annual non-employee director equity compensation program for the 2024-2025 term. These equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders.

SEC source: 0001819790-24-000077 · wk-form4_1718400820.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-24-000077 · wk-form4_1718400820.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-24-000008 · wk-form4_1706650295.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-01-24

F1 · derivative.exercise_date: Option granted in connection with certain consulting services being provided by the Reporting Person. The option will vest in full on January 30, 2025, subject to the Reporting Person's continuous service through such date.

SEC source: 0001209191-23-050429 · doc4.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,855

SEC source: 0001819790-23-000073 · wk-form4_1692309770.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 15,866

SEC source: 0001819790-23-000056 · wk-form4_1687816146.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Underlying: Common Stock · 3,350 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-23-000056 · wk-form4_1687816146.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2033-06-21

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-23-000042 · wk-form4_1687385681.xml · derivative · entry 4

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001819790-23-000042 · wk-form4_1687385681.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

SEC source: 0001209191-23-038168 · doc4.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,256

Underlying: Common Stock · 6,256 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The options vest on the earlier of June 15, 2024 or the Corporation's 2024 Annual Shareholders Meeting, subject to her continued service through the vesting date.

SEC source: 0001628280-22-025078 · wf-form4_166335986585757.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse's Roth IRA

Disclosed balance after: 6,360

SEC source: 0001628280-22-025078 · wf-form4_166335986585757.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401(k) Plan

Disclosed balance after: 12,040

F1 · price: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $15.94 to $16.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001209191-22-038107 · doc4.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,765

Underlying: Common Stock · 5,765 shares

Expires 2032-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date.

SEC source: 0001209191-22-038107 · doc4.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock.

SEC source: 0001628280-22-018343 · wf-form4_165669257959779.xml · derivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Underlying: Common Stock · 2,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001628280-22-018343 · wf-form4_165669257959779.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Underlying: Common Stock · 7,000 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

SEC source: 0001209191-22-001245 · doc4.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-12-31

F1 · derivative.exercise_date: The option shares vest in 3 annual installments beginning on December 31, 2022, subject to the Reporting Person's continuous service.

SEC source: 0001209191-21-043365 · doc4.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,703

Underlying: Common Stock · 1,703 shares

Expires 2031-06-23

F1 · derivative.exercise_date: The options vest on the earlier of June 24, 2022 or the Corporation's 2022 Annual Shareholders Meeting.

SEC source: 0001209191-21-005475 · doc4.xml · derivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,367

Underlying: Common Stock · 1,367 shares

Expires 2030-01-20

F1 · derivative.exercise_date: The options vest on the earlier of July 30, 2021 or the Corporation's 2021 Annual Shareholders Meeting.